SCHEMBL19523258

SCHEMBL19523258

CN(C)C(=O)c1cccc(CNC2=Nc3ccccc3NC23CCCCC3)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 6/20 0.37
▸ ALDH1A1 P00352 5/20 0.37
▸ CYP3A4 P08684 4/20 0.37
▸ CYP2C19 P33261 4/20 0.37
▸ HPGD P15428 3/20 0.37
▸ TSHR P16473 3/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ FYN P06241 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ ROCK2 O75116 2/20 0.36
▸ CYP2D6 P10635 3/20 0.36
▸ USP2 O75604 1/20 0.36
▸ HSD17B10 Q99714 4/20 0.35
▸ PARP1 P09874 4/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19523244 0.92 FYN (0.38) CYP1A2ALDH1A1CYP3A4CYP2C19HPGD
SCHEMBL19523089 0.92 FYN (0.38) CYP1A2ALDH1A1CYP3A4CYP2C19HPGD
SCHEMBL19523217 0.91 PIK3CB (0.40) CYP1A2ALDH1A1CYP3A4CYP2C19HPGD
SCHEMBL19523228 0.89 CYP1A2 (0.41) CYP1A2ALDH1A1CYP3A4CYP2C19HPGD
SCHEMBL17757867 0.88 PPM1D (0.44) CYP2D6LMNAHIF1AOPRM1KMT2A
SCHEMBL19523254 0.88 TDO2 (0.39) NPC1RAB9AL3MBTL1ROCK2PARP1
SCHEMBL19934614 0.88 HIF1A (0.44) TSHRSMN1; SMN2NPC1RAB9AROCK2
SCHEMBL17757589 0.86 WDR5 (0.40) CYP1A2ALDH1A1CYP3A4CYP2C19HPGD
SCHEMBL17757624 0.85 WDR5 (0.39) CYP1A2ALDH1A1CYP3A4CYP2C19HPGD
SCHEMBL17992105 0.84 KMT2A (0.33) TSHRPARP1HIF1AKMT2AESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE48992-E1 Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death HELMHOLTZ ZENTRUM MÜNCHEN-DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2022-03-29 — — US disclosed
US-10647687-B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death HELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2020-05-12 — — US disclosed
US-10280179-B2 Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death HELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2019-05-07 — — US disclosed
US-20180065982-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH HELMHOLTZ ZENTRUM MUNCHEN DEUTSCHES FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT (GMBH) (DE) 2018-03-08 — — US disclosed
US-9802956-B2 Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death HELMHOLTZ ZENTRUM MUNCHEN-DEUTSCHES FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT (GMBH) (DE) 2017-10-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647687-B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death AIFM2, BAD, AIFM1 CYP1A2 3995/4885ALDH1A1 2889/4885CYP3A4 4048/4885
US-10280179-B2 Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death AIFM2, BAD, AIFM1 CYP1A2 4621/4885ALDH1A1 3845/4885CYP3A4 4375/4885
US-20180065982-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH AIFM2, BAD, AIFM1 CYP1A2 4579/4885ALDH1A1 3830/4885CYP3A4 4330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback